Biolase (BIOL)
OTHER OTC:BIOL
US Market
Holding BIOL?
Track your performance easily

Biolase (BIOL) Financial Statements

1,635 Followers

Biolase Financial Overview

Biolase's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Biolase is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Mar 23Dec 22
Income Statement-
Total Revenue$ 11.55M$ 10.13M$ 10.92M$ 10.47M$ 14.05M
Gross Profit$ 4.61M$ 3.34M$ 3.75M$ 3.34M$ 3.60M
EBIT$ -2.18M$ -5.87M$ -3.97M$ -6.45M$ -8.36M
EBITDA$ -1.41M$ -5.08M$ -3.31M$ -6.19M$ -7.23M
Net Income Common Stockholders$ -2.80M$ -6.49M$ -4.59M$ -5.85M$ -9.43M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.27M$ 6.39M$ 7.81M$ 6.50M$ 4.18M
Total Assets$ 30.64M$ 34.35M$ 38.74M$ 41.94M$ 38.19M
Total Debt$ 13.74M$ 14.55M$ 15.10M$ 15.33M$ 15.05M
Net Debt$ 8.47M$ 8.16M$ 7.29M$ 8.83M$ 10.87M
Total Liabilities$ 32.77M$ 34.08M$ 32.86M$ 33.79M$ 33.30M
Stockholders Equity$ -3.98M$ -1.93M$ 332.00K$ 8.16M$ 4.89M
Cash Flow-
Free Cash Flow$ -674.00K$ -5.74M$ -2.77M$ -6.25M$ -6.07M
Operating Cash Flow$ -734.00K$ -5.94M$ -2.59M$ -5.66M$ -5.60M
Investing Cash Flow$ 60.00K$ 197.00K$ -182.00K$ -587.00K$ -444.00K
Financing Cash Flow$ -428.00K$ 5.65M$ 3.76M$ 8.51M$ -32.00K
Currency in USD

Biolase Earnings and Revenue History

Biolase Debt to Assets

Biolase Cash Flow

Biolase Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis